Skip to main content

New Approaches in the Management of Hyperkinetic Movement Disorders

  • Chapter
  • First Online:
Parkinson’s Disease

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 90))

Abstract

This review covers recent advances in a variety of dyskinesias. Introduction of new drugs for the treatment of myoclonus and sensory biofeedback therapy for focal dystonia are expanding our concepts of these types of movement disorders. Progress in the treatment of action myoclonus is especially noteworthy and has led to the impli cation of serotonin deficit in the pathophysiology of this syndrome. Knowledge of the biochemical pathology of Huntington’s chorea has outpaced therapy for this disorder, but new forms of therapy have been proposed based on the chemical findings. Basic pharmacologic studies suggest pathophysiologic mechanisms for the syndrome known as tardive dyskinesia, but treatment is still far from ideal for this disorder. Other movement disorders with recent therapeutic advances include essential tremor and hemiballism

This review will cover only those dyskinesias in which new therapies have been advanced in the last few years. Aside from parkinsonism, which will not be discussed here, progress in the treatment of movement disorders has been slow, but steady. New drugs are being tested constantly, and the purpose of this review is to call attention to the ongoing evaluations in this field. Descriptions and etiologies for these dyskinesias are covered elsewhere (Fahn, 1976a) and therefore are not repeated here.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Allen, N. and Knopp, W. (1976). Hereditary parkinsonsim-dystonia with sustained control by L-dopa and anticholinergic medica tion. In: Dystonia. Advances in Neurology, Vol. 14. (Eldridge, R. and Fahn, S., Eds.) pp. 201–213. Raven Press, New York.

    Google Scholar 

  • Barrett, R.E., Yahr, M.D. and Duvoisin, R.C. (1970). Torsion dystonia and spasmodic torticollis: results of treatment with L-dopa. Neurology 20 ,107–113.

    Article  CAS  Google Scholar 

  • Batshaw, M.L. and Haslam, R.H.A. (1970). Multidisciplinary management of dystonia misdiagnosed as hysteria. In: Dystonia. Advances in Neurology, Vol. 14. (Eldridge, R. and Fahn, S., Eds.) pp. 367–373. Raven Press, New York.

    Google Scholar 

  • Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K. and Seitelberger, F. (1973). Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological and neurochemical correlations. J. Neuroí. Sci. 20 ,415–455.

    Article  CAS  Google Scholar 

  • Charlton, M.H., (Ed.) (1975), Myoolonie Seizures ,Excerpta Medica, International Congress Series, No. 307, Amsterdam.

    Google Scholar 

  • Chase, T.N. (1970). Biochemical and pharmacologic studies of dystonia. Neurology 20 ,122–126.

    Article  CAS  Google Scholar 

  • Coleman, M. (1970). Preliminary remarks on the L-dopa therapy of dystonia. Neurology 20 ,114–122.

    Article  CAS  Google Scholar 

  • Cooper, I.S. (1972). Levodopa-induced dystonia. Lancet 2, 1317–1318.

    Article  CAS  Google Scholar 

  • Cooper, I.S. (1976). Twenty-year followup study of the neurosurgical treatment of dystonia musculorum deformans. In: Dystonia. Advances in Neurology, Vol. 14. (Eldridge, R. and Fahn, S., Eds) pp. 423–452. Raven Press, New York.

    Google Scholar 

  • Courville, C.B. (1953). Contributions to the Study of Cerebral Anoxia. Los Angeles, San Lucas Press.

    Google Scholar 

  • Crane, G.E. (1972). Pseudoparkinsonism and tardive dyskinesia. Arch. Neurol. 27 ,426–430.

    Article  CAS  Google Scholar 

  • DeLean, J., Richardson, J.C. and Hornykiewicz, O. (1976). Benefi cial effects of serotonin precursors in postanoxic action myoclonus. Neurology 26 ,863–868.

    Article  CAS  Google Scholar 

  • Eldridge, R. and Fahn, S. (Eds.) (1976). Dystonia. Advances in Neurology, Vol. 14, Raven Press, New York.

    Google Scholar 

  • Fahn, S. (1972a). Differential diagnosis of tremors. Med. Chin. No. Am. 56 ,1363–1375.

    CAS  Google Scholar 

  • Fahn, S. (1972b). Treatment of choreic movements with perphenazine. Bis. Nerv. Syst. 33, 653–658.

    CAS  Google Scholar 

  • Fahn, S. (1974). “On-off” phenomenon with levodopa therapy in parkinsonism: Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine. Neurology 24 ,431–441.

    Article  CAS  Google Scholar 

  • Fahn, S. (1976a). Medical treatment of movement disorders. In Neurological Reviews 1976. pp. 72–106. American Academy of Neurology, Minneapolis.

    Google Scholar 

  • Fahn, S. (1976b). Biochemistry of the basal ganglia. In: Dystonia. Advances in Neurology, Vol. 14. (Eldridge, R. and Fahn, S., Eds.) pp. 59–88. Raven Press, New York.

    Google Scholar 

  • Fahn, S. (in press). Gamma-aminobutyric acid, glycine and other putative amino acid neurotransmitters. In: Handbook of Clinical Neurology.

    Google Scholar 

  • Fahn, S. and Eldridge, R. (1976). Definition of dystonia and classification of the dystonic states. In: Dystonia. Advances in Neurology, Vol. 14. (Eldridge, R. and Fahn, S., Eds.) pp. 1–5. Raven Press, New York.

    Google Scholar 

  • Geller, M., Kaplan, B., and Christoff, N. (1976). Treatment of dystonic symptoms with carbamazepine. In: Dystonia. Advances in Neurology, Vol. 14. (Eldridge, R. and Fahn, S., Eds.) pp. 403–410. Raven Press, New York.

    Google Scholar 

  • Goldberg, M.A. and Dorman, J.D. (1976). Intention myoclonus: Successful treatment with clonazepam. Neurology 26 ,24–26.

    Article  Google Scholar 

  • Hirose, G., Singer, P., Bass, N.H. (1971). Successful treatment of posthypoxic action myoclonus with carbamazepine. J.A.M.A. 218 ,1432–1433.

    Article  CAS  Google Scholar 

  • Hoehn, M.M. and Cherington, M. (in press). Spinal myoclonus. Neurology ,in press.

    Google Scholar 

  • Isgreen, W.P., Fahn, S., Barrett, R.E., Snider, S.R. and Chutorian, A.M. (1976). Carbamazepine in torsion dystonia. In: Dysto nia. Advances in Neurology, Vol. 14. (Eldridge, R. and Fahn, S., Eds.) pp. 411–416. Raven Press, New York.

    Google Scholar 

  • Johnson, W.G. and Fahn, S. (1974). Treatment of vascular hemichorea and hemiballismus with perphenazine. Trans. Am. Neurol. Assoc. 99 ,22–224.

    Google Scholar 

  • Johnston, G.A.R. (1976). Physiologic pharmacology of GABA and its antagonists in the vertebrate nervous system. In: GABA in Nervous System Function (Roberts, E., Chase, T.N., and Tower, D.B., Eds) pp. 395–411. Raven Press, New York.

    Google Scholar 

  • Klawans, H.L. (1973). The pharmacology of tardive dyskinesias. Am. J. Psyohiat. 130 ,82–86.

    Article  Google Scholar 

  • Korein, J., Brudney, J., Grynbaum, B., Sachs-Frankel, G., Weisinger, M., and Levidow, L. (1976). Sensory feedback therapy of spasmodic torticollis and dystonia: Results in treatment of 55 patients. In: Dystonia. Advances in Neurology, Vol. 14. (Eldridge, R. and Fahn, S., Eds.) pp. 375–402. Raven Press, New York.

    Google Scholar 

  • Lance, J.W. and Adams, R.D. (1963). The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy. Brain 86 ,111–136.

    Article  CAS  Google Scholar 

  • Lhermitte, F., Marteau, R. and Degos, L.-F. (1972). Analyse pharmacologique d’un nouveau cas de myoclonies d’intention et d’action post-anoxiques. Rev. Neurol. Paris 126 ,107–114.

    CAS  PubMed  Google Scholar 

  • Lhermitte, F., Peterflavi, M., Marteau, R., Gazengel, J. and Serdaru, M. (1971). Analyse pharmacologique d’un cas de myoclonies d’intention et d’action post-anoxiques. Rev. Neurol. Paris. 124 ,23–31.

    Google Scholar 

  • McGeer, P.L. and McGeer, E.G. (1976). The GABA system and function of the basal ganglia: Huntington’s disease. In: GABA in Nervous System Function. (Roberts, E., Chase, T.N., and Tower, D.B., Eds.) pp. 487–495. Raven Press, New York.

    Google Scholar 

  • Rajput, A.H. (1973). Levodopa in dystonia musculorum deformans. Lancet 1 ,432.

    Article  CAS  Google Scholar 

  • Shapiro, A.K., Shapiro, E.S., Bruun, R.D., Sweet, R., Wayne, H. and Solomon, G. (1976). Gilles de la Tourette’s syndrome: Summary of clinical experience with 250 patients and suggested nomenclature for tic syndromes. In: Dystonia. Advances in Neurology, Vol. 14. (Eldridge, R. and Fahn, S., Eds.) pp. 277–283. Raven Press, New York.

    Google Scholar 

  • Shoulson, I., Kartzinel, R., and Chase, T.N. (1976). Huntingtons disease: Treatment with dipropylacetic acid and gamma-aminobutyric acid. Neurology 26 ,61–63.

    Article  CAS  Google Scholar 

  • Stahl, W.L. and Swanson, P.D. (1974). Biochemical abnormalities in Huntington’s chorea brains. Neurology 24 ,813–819.

    Article  CAS  Google Scholar 

  • Sweet, R.D., Blumberg, J., Lee, J.E., and McDowell, F.H. (1974). Propranolol treatment of essential tremor. Neurology 24, 64–67.

    Article  CAS  Google Scholar 

  • Tolosa, E.S. and Loewenson, R.B. (1975). Essential tremor: treatment with propranolol. Neurology 25 ,1041–1044.

    Article  CAS  Google Scholar 

  • Urquhart, N., Perry, T.L., Hansen, S. and Kennedy, J. (1975). GABA content and glutamic acid decarboxylase activity in brain of Huntington’s chorea patients and control subjects. J. Neurochem. 24 ,1071–1075.

    Article  CAS  Google Scholar 

  • Van Woert, M.H., Jutkowitz, R., Rosenbaum, P. and Bowers, M.B., Jr. (1976). Serotonin and myoclonus. Monagr. Neural Sci. 3 ,71–80.

    Google Scholar 

  • Van Woert, M.H. and Sethy, V.H. (1975). Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486. Neurology 25 ,135–140.

    Article  Google Scholar 

  • Winkler, G.F. and Young, R.R. (1974). Efficacy of chronic propranolol therapy in action tremors of the familial, senile or essential varieties. N. Engl. J. Med. 290 ,984–988.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1977 Plenum Press, New York

About this chapter

Cite this chapter

Fahn, S. (1977). New Approaches in the Management of Hyperkinetic Movement Disorders. In: Messiha, F.S., Kenny, A.D. (eds) Parkinson’s Disease. Advances in Experimental Medicine and Biology, vol 90. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-2511-6_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-2511-6_7

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4684-2513-0

  • Online ISBN: 978-1-4684-2511-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics